Characteristics | Overall* N = 441 | HIV positive n = 79 (18.0%) | HIV negative n = 361 (82.0%) | p-value |
---|---|---|---|---|
Socio-Demographic | Â | Â | Â | Â |
 Age (years)§, median (IQR) | 42 (31–55) | 45 (37–52) | 42(30–56) | 0.463a |
 Age groups, n (%) |  |  |  |  |
 20 years or younger | 16 (3.6) | 1 (1.3) | 15 (4.2) | 0.001 b |
 21–35 years | 133 (30.2) | 16 (20.3) | 117 (32.4) |  |
 36–50 years | 142 (32.3) | 40 (50.6) | 102 (28.3) |  |
 Older than 50 years | 150 (34.0) | 22 (27.9) | 127 (35.2) |  |
 Males, n (%) | 295 (67.1) | 51 (64.6) | 244 (67.6) | 0.600b |
 Education attained |  |  |  |  |
 Primary or less | 233 (53.0) | 52 (65.8) | 181 (50.1) | 0.034 b |
 Secondary | 139 (31.6) | 20 (25.3) | 119 (33.0) |  |
 Tertiary | 68 (15.4) | 7 (8.9) | 61 (16.9) |  |
 Alcohol consumption, n (%) | 194 (44.1) | 48 (60.8) | 146 (40.4) | 0.001 b |
 Cigarette smoking, n (%) | 82 (19.0) | 22 (28.0) | 60 (17.0) | 0.025 b |
Clinical | Â | Â | Â | Â |
 Physical activity, Karnofsky score, < 50, n (%) | 44 (10.1) | 10 (12.7) | 34(9.5) | 0.39 b |
 Hand grip strength, > 45 pounds, n (%) | 188 (47.0) | 31 (41.3) | 157 (48.2) | 0.310b |
Laboratory | Â | Â | Â | Â |
 HBsAg positive, n (%) | 192 (43.9) | 35 (44.9) | 157 (43.6) | 0.900b |
 Anti-HCV positive, n (%) | 30 (6.9) | 2 (2.5) | 28 (7.8) | 0.137b |
 Active Schistosomiasis (Urine CCA) positive, n (%) | 214 (52.8) | 37 (50.0) | 177 (53.5) | 0.610b |
 AST (U/l), > 45, n (%) | 344 (78.2) | 69 (87.3) | 275 (76.2) | 0.035 b |
 ALT (U/l), > 40, n (%) | 244 (55.5) | 48 (60.8) | 196 (54.3) | 0.319b |
 INR > 1.15, n (%) | 351 (82.2) | 66 (86.8) | 285 (81.2) | 0.321b |
 AFP (IU/mL), ≥ 100, n (%) | 218 (50.2) | 39 (50.0) | 179 (50.3) | 1.000b |
 AFP (IU/mL), ≥ 400, n (%) | 199 (45.9) | 33 (42.3) | 166 (46.6) | 0.532b |
 HIV load (copies/ml) c |  |  |  |  |
 <200 | -- | 51(64.6) | -- |  |
 ≥200 | -- | 28(35.4) | -- |  |
 CD4 cell count (cells/mm3) d  <200  ≥200 |  |  |  |  |
 <200 | -- | 21(26.6) | -- |  |
 ≥200 | -- | 58(73.4) | -- |  |
Ultrasound imaging | Â | Â | Â | Â |
 Multifocal disease, n (%) | 316 (73.6%) | 61(77.2) | 255 (72.9%) | 0.730b |